{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:57:57Z","timestamp":1783792677738,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-025-07792-3","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:39:38Z","timestamp":1767641978000},"page":"1323-1336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PAFLAR guidelines for oligoarticular juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-6804","authenticated-orcid":false,"given":"Waleed","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1220-7215","authenticated-orcid":false,"given":"Doaa Mosad","family":"Mosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Faleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4452-5573","authenticated-orcid":false,"given":"Temesgen Teferi","family":"Libe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Palalane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-7963","authenticated-orcid":false,"given":"Angela","family":"Migowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-6698","authenticated-orcid":false,"given":"Sulaiman","family":"Al Mayouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8824-2546","authenticated-orcid":false,"given":"Helen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-8598","authenticated-orcid":false,"given":"Mohammed Hassan","family":"Abu-Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soad","family":"Hashad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3045-4831","authenticated-orcid":false,"given":"Wafa","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-0936","authenticated-orcid":false,"given":"Hanene Lassoued","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Lishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6523-9851","authenticated-orcid":false,"given":"Chafia Makhloufi","family":"Dahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Makhlouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaninga Halwani","family":"Fusseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassila","family":"Messadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-076X","authenticated-orcid":false,"given":"Ali","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8875-2455","authenticated-orcid":false,"given":"Samah Ismail","family":"Nasef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-0569","authenticated-orcid":false,"given":"Ourida","family":"Gacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Ngandeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-3041","authenticated-orcid":false,"given":"Francis Fredrick","family":"Furia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-3551","authenticated-orcid":false,"given":"Samy","family":"Slimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1949-4966","authenticated-orcid":false,"given":"Djohra","family":"Hadef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"2","key":"7792_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"key":"7792_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res Hoboken 63:929\u2013936. https:\/\/doi.org\/10.1002\/acr.20497","journal-title":"Arthritis Care Res Hoboken"},{"issue":"4","key":"7792_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5114\/reum.2019.87607","volume":"57","author":"Z \u017buber","year":"2019","unstructured":"\u017buber Z (2019) Oligoarticular onset juvenile idiopathic arthritis as the most common cause of disability of children and young adults. Rheumatology 57(4):189\u2013191. https:\/\/doi.org\/10.5114\/reum.2019.87607","journal-title":"Rheumatology"},{"key":"7792_CR4","doi-asserted-by":"publisher","unstructured":"Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K; German Uveitis in Childhood Study Group (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 46(6):1015-9. https:\/\/doi.org\/10.1093\/rheumatology\/kem053","DOI":"10.1093\/rheumatology\/kem053"},{"issue":"1","key":"7792_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2319-4170.106171","volume":"35","author":"JL Huang","year":"2012","unstructured":"Huang JL (2012) New advances in juvenile idiopathic arthritis. Chang Gung Med J 35(1):1\u201314. https:\/\/doi.org\/10.4103\/2319-4170.106171","journal-title":"Chang Gung Med J"},{"key":"7792_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465\u2013482. https:\/\/doi.org\/10.1002\/acr.20460","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7792_CR7","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P et al (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991\u20131994","journal-title":"J Rheumatol"},{"issue":"11","key":"7792_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3345\/kjp.2010.53.11.931","volume":"53","author":"KH Kim","year":"2010","unstructured":"Kim KH, Kim DS (2010) Juvenile idiopathic arthritis: diagnosis and differential diagnosis. Korean J Pediatr 53(11):931\u2013935. https:\/\/doi.org\/10.3345\/kjp.2010.53.11.931","journal-title":"Korean J Pediatr"},{"issue":"2","key":"7792_CR9","first-page":"367","volume":"26","author":"JK Reininga","year":"2008","unstructured":"Reininga JK, Los LI, Wulffraat NM, Armbrust W (2008) The evaluation of uveitis in juvenile idiopathic arthritis (JIA) patients: are current ophthalmologic screening guidelines adequate? Clin Exp Rheumatol 26(2):367\u2013372","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"7792_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3928\/0191-3913-19980101-13","volume":"35","author":"MI Boone","year":"1998","unstructured":"Boone MI, Moore TL, Cruz OA (1998) Screening for uveitis in juvenile rheumatoid arthritis. J Pediatr Ophthalmol Strabismus 35(1):41\u201343. https:\/\/doi.org\/10.3928\/0191-3913-19980101-13","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"7792_CR11","first-page":"630","volume":"39","author":"C Boros","year":"2010","unstructured":"Boros C, Whitehead B (2010) Juvenile idiopathic arthritis. Aust Fam Physician 39:630\u2013636","journal-title":"Aust Fam Physician"},{"key":"7792_CR12","unstructured":"Petty RE, Laxer RM, Wedderburn LR (2021) Juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR (eds) Textbook of pediatric rheumatology, 8th edn. Elsevier Saunders, Philadelphia, pp 209\u2013215"},{"issue":"8","key":"7792_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","volume":"77","author":"T Constantin","year":"2018","unstructured":"Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C et al (2018) Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis 77(8):1107\u20131117. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213131","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7792_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML et al (2019) 2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res Hoboken 71(6):703\u2013716. https:\/\/doi.org\/10.1002\/acr.23871","journal-title":"Arthritis Care Res Hoboken"},{"issue":"2","key":"7792_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/rheumatology\/ket310","volume":"53","author":"M Bulatovi\u0107 Calasan","year":"2014","unstructured":"Bulatovi\u0107 Calasan M, de Vries LD, Vastert SJ, Heijstek MW, Wulffraat NM (2014) Interpretation of the juvenile arthritis disease activity score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis. Rheumatol (Oxford) 53(2):307\u2013312. https:\/\/doi.org\/10.1093\/rheumatology\/ket310","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s43166-022-00125-1","volume":"49","author":"Y El Miedany","year":"2022","unstructured":"El Miedany Y, Salah S, Lotfy H, El Gaafary M, Abdulhady H, Salah H et al (2022) Updated clinical practice treat-to-target guidelines for JIA management: the Egyptian College of Pediatric Rheumatology initiative. Egypt Rheumatol Rehabil 49:27. https:\/\/doi.org\/10.1186\/s43166-022-00125-1","journal-title":"Egypt Rheumatol Rehabil"},{"issue":"4","key":"7792_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/acr.24853","volume":"74","author":"KB Onel","year":"2022","unstructured":"Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST et al (2022) 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res Hoboken 74(4):521\u2013537. https:\/\/doi.org\/10.1002\/acr.24853","journal-title":"Arthritis Care Res Hoboken"},{"issue":"6","key":"7792_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/acr.23870","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML et al (2019) 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Care Res 71(6):717\u2013734. https:\/\/doi.org\/10.1002\/acr.23870","journal-title":"Arthritis Care Res"},{"key":"7792_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/keg358","volume":"42","author":"F Zulian","year":"2003","unstructured":"Zulian F, Martini G, Gobber D, Agosto C, Gigante C, Zacchello F (2003) Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis. Rheumatol (Oxford) 42:1254\u20131259. https:\/\/doi.org\/10.1093\/rheumatology\/keg358","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR20","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/rheumatology\/keh313","volume":"43","author":"F Zulian","year":"2004","unstructured":"Zulian F, Martini G, Gobber D, Plebani M, Zacchello F, Manners P (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatol (Oxford) 43:1288\u20131291. https:\/\/doi.org\/10.1093\/rheumatology\/keh313","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR21","first-page":"2507","volume":"31","author":"BA Eberhard","year":"2004","unstructured":"Eberhard BA, Sison MC, Gottlieb BS, Ilowite NT (2004) Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 31:2507\u20132512","journal-title":"J Rheumatol"},{"key":"7792_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.reuma.2018.07.015","volume":"15","author":"JC Nieto-Gonz\u00e1lez","year":"2019","unstructured":"Nieto-Gonz\u00e1lez JC, Monteagudo I (2019) Intra-articular joint injections in juvenile idiopathic arthritis: state of the art. Reumatol Clin 15:69\u201372. https:\/\/doi.org\/10.1016\/j.reuma.2018.07.015","journal-title":"Reumatol Clin"},{"issue":"3","key":"7792_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/archdischild-2020-321088","volume":"107","author":"D McKenna","year":"2022","unstructured":"McKenna D, McLaughlin D, Campbell C, Mulholland M, Thompson A, Loughran C et al (2022) Fifteen-minute guide to managing oligoarticular juvenile idiopathic arthritis. Arch Dis Child Educ Pract Ed 107(3):175\u2013181. https:\/\/doi.org\/10.1136\/archdischild-2020-321088","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"12","key":"7792_CR24","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1007\/s10067-022-06327-4","volume":"41","author":"F Ayd\u0131n","year":"2022","unstructured":"Ayd\u0131n F, \u00c7akar N, Kurt T, \u00c7elikel Acar B, \u00c7elikel E, \u00d6z\u00e7akar ZB et al (2022) What are the factors associated with the duration of remission of intra-articular corticosteroid injection in juvenile idiopathic arthritis? Clin Rheumatol 41(12):3791\u20133796. https:\/\/doi.org\/10.1007\/s10067-022-06327-4","journal-title":"Clin Rheumatol"},{"issue":"1","key":"7792_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00666-x","volume":"20","author":"S Rubin","year":"2022","unstructured":"Rubin S, Ohana O, Goldberg O, Peled O, Gendler Y, Habot-Wilner Z et al (2022) The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis. Pediatr Rheumatol Online J 20(1):5. https:\/\/doi.org\/10.1186\/s12969-022-00666-x","journal-title":"Pediatr Rheumatol Online J"},{"key":"7792_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1080\/14397595.2018.1516329","volume":"29","author":"E Alexeeva","year":"2019","unstructured":"Alexeeva E, Dvoryakovskaya T, Denisova R, Sleptsova T, Isaeva K, Chomahidze A et al (2019) Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching method. Mod Rheumatol 29:848\u2013855. https:\/\/doi.org\/10.1080\/14397595.2018.1516329","journal-title":"Mod Rheumatol"},{"key":"7792_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/rheumatology\/kes373","volume":"52","author":"J Anink","year":"2013","unstructured":"Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF et al (2013) Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch arthritis and biologicals in children register. Rheumatol (Oxford) 52:712\u2013717. https:\/\/doi.org\/10.1093\/rheumatology\/kes373","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"P Tynjala","year":"2011","unstructured":"Tynjala P, Vahasalo P, Tarkiainen M, Kroger L, Aalto K, Malin M et al (2011) Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised openlabel clinical trial. Ann Rheum Dis 70:1605\u20131612. https:\/\/doi.org\/10.1136\/ard.2010.143347","journal-title":"Ann Rheum Dis"},{"key":"7792_CR29","doi-asserted-by":"publisher","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ et al (2000) Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763\u20139. https:\/\/doi.org\/10.1056\/NEJM200003163421103","DOI":"10.1056\/NEJM200003163421103"},{"key":"7792_CR30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3899\/jrheum.200437","volume":"48","author":"ML Mannion","year":"2020","unstructured":"Mannion ML, Xie F, Horton DB, Ringold S, Correll CK, Dennos A et al (2020) Biologic switching among non-systemic juvenile idiopathic arthritis patients: a cohort study in the Childhood Arthritis and Rheumatology Research Alliance Registry. J Rheumatol 48:1322\u20131329. https:\/\/doi.org\/10.3899\/jrheum.200437","journal-title":"J Rheumatol"},{"key":"7792_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13075-020-02326-5","volume":"22","author":"G Armaroli","year":"2020","unstructured":"Armaroli G, Klein A, Ganser G, Ruehlmann MJ, Dressler F, Hospach A et al (2020) Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry. Arthritis Res Ther 22:258. https:\/\/doi.org\/10.1186\/s13075-020-02326-5","journal-title":"Arthritis Res Ther"},{"key":"7792_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2018-eular.2788","volume":"77","author":"Y Atef","year":"2018","unstructured":"Atef Y, Lotfy H, El Aroussy N, Mekkawy D, Hassan W, Nasef SI et al (2018) THU0555 guidelines for juvenile idiopathic arthritis management: is there a room for combined methotrexate and leflunomide therapy in the treatment recommendations. Ann Rheum Dis 77:480","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7792_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.paed.03.005","volume":"32","author":"CK Warrier","year":"2022","unstructured":"Warrier CK (2022) A practical guide to using biologics in juvenile idiopathic arthritis. Paediatr Child Health 32(6):229\u2013235. https:\/\/doi.org\/10.1016\/j.paed.03.005","journal-title":"Paediatr Child Health"},{"issue":"14","key":"7792_CR34","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.3390\/jcm12144695","volume":"12","author":"I Melki","year":"2023","unstructured":"Melki I, Fr\u00e9mond ML (2023) JAK inhibition in juvenile idiopathic arthritis (JIA): better understanding of a promising therapy for refractory cases. J Clin Med 12(14):4695. https:\/\/doi.org\/10.3390\/jcm12144695","journal-title":"J Clin Med"},{"issue":"1","key":"7792_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.46497\/ArchRheumatol.2021.7953","volume":"36","author":"A Adrovic","year":"2020","unstructured":"Adrovic A, Yildiz M, K\u00f6ker O, \u015eahin S, Barut K, Kasap\u00e7opur \u00d6 (2020) Biologics in juvenile idiopathic arthritis-main advantages and major challenges: a narrative review. Arch Rheumatol 36(1):146\u2013157. https:\/\/doi.org\/10.46497\/ArchRheumatol.2021.7953","journal-title":"Arch Rheumatol"},{"key":"7792_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2147\/BTT.S486359","volume":"19","author":"A Civino","year":"2025","unstructured":"Civino A, Diomeda F, Burrone M, Natoli V, Ravelli A (2025) Update on biologic therapy in juvenile idiopathic arthritis: a five-year narrative review. Biologics 19:425\u2013441. https:\/\/doi.org\/10.2147\/BTT.S486359","journal-title":"Biologics"},{"key":"7792_CR37","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli A, Davi S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EH et al (2017) Intra-articular corticosteroids versus intraarticular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, openlabel trial. Lancet 389:909\u2013916. https:\/\/doi.org\/10.1016\/S0140-6736(17)30065-X","journal-title":"Lancet"},{"issue":"10","key":"7792_CR38","doi-asserted-by":"publisher","first-page":"822009","DOI":"10.3389\/fped.2022.822009","volume":"29","author":"S Li","year":"2022","unstructured":"Li S, Zhang W, Lin Y (2022) Application of intra-articular corticosteroid injection in juvenile idiopathic arthritis. Front Pediatr 29(10):822009. https:\/\/doi.org\/10.3389\/fped.2022.822009","journal-title":"Front Pediatr"},{"issue":"12","key":"7792_CR39","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ et al (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63(12):1638\u20131644. https:\/\/doi.org\/10.1136\/ard.2003.014886","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7792_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003010","volume":"9","author":"JW van Straalen","year":"2023","unstructured":"van Straalen JW, Akay G, Kouwenberg CV, de Roock S, Kalinina Ayuso V, Wulffraat NM et al (2023) Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-na\u00efve juvenile idiopathic arthritis. RMD Open 9(2):e003010. https:\/\/doi.org\/10.1136\/rmdopen-2023-003010","journal-title":"RMD Open"},{"key":"7792_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/rhe1","volume":"9","author":"M Brattstr\u00f6m","year":"1963","unstructured":"Brattstr\u00f6m M (1963) Asymmetry of ossification and rate of growth of long bones in children with unilateral juvenile gonarthritis. Acta Rheumatol Scand 9:102\u2013115. https:\/\/doi.org\/10.3109\/rhe1","journal-title":"Acta Rheumatol Scand"},{"issue":"10","key":"7792_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12103402","volume":"12","author":"C Klein","year":"2023","unstructured":"Klein C, Barbier V, Glorion C, Gouron R (2023) Surgical treatment of juvenile idiopathic arthritis in the era of novel drug therapies. J Clin Med 12(10):3402. https:\/\/doi.org\/10.3390\/jcm12103402","journal-title":"J Clin Med"},{"key":"7792_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MOP.0b013e3282f35eeb","volume":"20","author":"L Friend","year":"2008","unstructured":"Friend L, Widmann RF (2008) Advances in management of limb length discrepancy and lower limb deformity. Curr Opin Pediatr 20:46\u201351. https:\/\/doi.org\/10.1097\/MOP.0b013e3282f35eeb","journal-title":"Curr Opin Pediatr"},{"key":"7792_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3928\/0147-7447-19780701-08","volume":"1","author":"RH Gross","year":"1978","unstructured":"Gross RH (1978) Leg length discrepancy: how much is too much? Orthopedics 1:307\u2013310. https:\/\/doi.org\/10.3928\/0147-7447-19780701-08","journal-title":"Orthopedics"},{"issue":"11","key":"7792_CR45","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/15290131(199911)","volume":"42","author":"DD Sherry","year":"1999","unstructured":"Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW (1999) Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum 42(11):2330\u20132334. https:\/\/doi.org\/10.1002\/15290131(199911)","journal-title":"Arthritis Rheum"},{"issue":"11","key":"7792_CR46","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/rheumatology\/ket150","volume":"52","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL (2013) Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. Rheumatol (Oxford) 52(11):1941\u20131951. https:\/\/doi.org\/10.1093\/rheumatology\/ket150","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-11-48","author":"W Armbrust","year":"2013","unstructured":"Armbrust W, Kaak JG, Bouma J, Lelieveld OT, Wulffraat NM, Sauer PJ et al (2013) Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists. Pediatr Rheumatol Online J. https:\/\/doi.org\/10.1186\/1546-0096-11-48","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"7792_CR48","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/rheumatology\/kev353","volume":"55","author":"M Backstr\u00f6m","year":"2016","unstructured":"Backstr\u00f6m M, Tynj\u00e4l\u00e4 P, Ylijoki H, Aalto K, K\u00e4rki J, Pohjankoski H et al (2016) Finding specific 10-joint juvenile arthritis disease activity score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study. Rheumatol (Oxford) 55(4):615\u2013623. https:\/\/doi.org\/10.1093\/rheumatology\/kev353","journal-title":"Rheumatol (Oxford)"},{"issue":"10","key":"7792_CR49","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/rheumatology\/kead151","volume":"3","author":"M Backstr\u00f6m","year":"2023","unstructured":"Backstr\u00f6m M, Tarkiainen M, Gottlieb BS, Trincianti C, Qiu T, Morgan E et al (2023) Paediatric rheumatologists do not score the physician\u2019s global assessment of juvenile idiopathic arthritis disease activity in the same way. Rheumatol (Oxford) 3(10):3421\u20133426. https:\/\/doi.org\/10.1093\/rheumatology\/kead151","journal-title":"Rheumatol (Oxford)"},{"key":"7792_CR50","doi-asserted-by":"publisher","unstructured":"Al-Mayouf SM, Hashad S, Khawaja K, Alrasheedi A, Abdwani R, Abushhaiwia A et al (2021) Pediatric Arab Rheumatology Group. Cumulative damage in juvenile idiopathic arthritis: a\u00a0multicenter study from the Pediatric Rheumatology Arab\u00a0Group. Arthritis Care Res (Hoboken) 73(4):586-592. https:\/\/doi.org\/10.1002\/acr.24436","DOI":"10.1002\/acr.24436"},{"issue":"7","key":"7792_CR51","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/art.21119","volume":"52","author":"S Viola","year":"2005","unstructured":"Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N et al (2005) Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 52(7):2092\u20132102. https:\/\/doi.org\/10.1002\/art.21119","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7792_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1950-7","volume":"21","author":"G Giancane","year":"2019","unstructured":"Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F et al (2019) Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther 21(1):168. https:\/\/doi.org\/10.1186\/s13075-019-1950-7","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"7792_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-023-00852-5","volume":"21","author":"S Tangcheewinsirikul","year":"2023","unstructured":"Tangcheewinsirikul S, Sukharomana M, Charuvanij S (2023) Disability and disease-related damage in Thai children and adolescents with juvenile idiopathic arthritis. Pediatr Rheumatol Online J 21(1):68. https:\/\/doi.org\/10.1186\/s12969-023-00852-5","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"7792_CR54","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.39145","volume":"67","author":"G Horneff","year":"2015","unstructured":"Horneff G, Foeldvari I, Minden K, Trauzeddel R, K\u00fcmmerle-Deschner JB, Tenbrock K et al (2015) Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study. Arthritis Rheumatol 67(8):2240\u20132249. https:\/\/doi.org\/10.1002\/art.39145","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"7792_CR55","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/annrheumdis-2017-211968","volume":"77","author":"J Klotsche","year":"2018","unstructured":"Klotsche J, Minden K, Niewerth M, Horneff G (2018) Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Ann Rheum Dis 77(7):996\u20131002. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211968","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"7792_CR56","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2010.375","volume":"303","author":"D Foell","year":"2010","unstructured":"Foell D, Wulffraat N, Wedderburn LR, Wittkowski H, Frosch M, Gerss J et al (2010) Paediatric rheumatology international trials organization (PRINTO). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 303(13):1266\u20131273. https:\/\/doi.org\/10.1001\/jama.2010.375","journal-title":"JAMA"},{"issue":"2","key":"7792_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/ard.2003.005686","volume":"63","author":"D Foell","year":"2004","unstructured":"Foell D, Frosch M, Schulze zur Wiesch A, Vogl T, Sorg C, Roth J (2004) Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 63(2):206\u2013208. https:\/\/doi.org\/10.1136\/ard.2003.005686","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7792_CR58","first-page":"229","volume":"45","author":"SA Azevedo","year":"2020","unstructured":"Azevedo SA, Ramos Rodrigues J, Guimar\u00e3es F, Almeida D, Pinto AS, Parente H et al (2020) Strategies for the withdrawal of classic and biological DMARD in clinically inactive patients with juvenile idiopathic arthritis. Acta Reumatol Port 45(3):229\u2013232","journal-title":"Acta Reumatol Port"},{"issue":"3","key":"7792_CR59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3899\/jrheum.161078","volume":"44","author":"DB Horton","year":"2017","unstructured":"Horton DB, Onel KB, Beukelman T, Ringold S (2017) Attitudes and approaches for withdrawing drugs for children with clinically inactive nonsystemic JIA: a survey of the childhood arthritis and rheumatology research alliance. J Rheumatol 44(3):352\u2013360. https:\/\/doi.org\/10.3899\/jrheum.161078","journal-title":"J Rheumatol"},{"issue":"10","key":"7792_CR60","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/art.30502","volume":"63","author":"K Baszis","year":"2011","unstructured":"Baszis K, Garbutt J, Toib D, Mao J, King A, White A et al (2011) Clinical outcomes after withdrawal of anti-tumor necrosis factor \u03b1 therapy in patients with juvenile idiopathic arthritis: a twelve-year experience. Arthritis Rheum 63(10):3163\u20133168. https:\/\/doi.org\/10.1002\/art.30502","journal-title":"Arthritis Rheum"},{"issue":"9","key":"7792_CR61","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s00296-012-2642-7","volume":"33","author":"Y Cai","year":"2013","unstructured":"Cai Y, Liu X, Zhang W, Xu J, Cao L (2013) Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission. Rheumatol Int 33(9):2277\u20132282. https:\/\/doi.org\/10.1007\/s00296-012-2642-7","journal-title":"Rheumatol Int"},{"issue":"7","key":"7792_CR62","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1136\/ard.2008.101030","volume":"68","author":"FH Prince","year":"2009","unstructured":"Prince FH, Twilt M, Simon SC, van Rossum MA, Armbrust W, Hoppenreijs EP et al (2009) When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis. Ann Rheum Dis 68(7):1228\u20131229. https:\/\/doi.org\/10.1136\/ard.2008.101030","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"7792_CR63","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/acr.23435","volume":"70","author":"G Simonini","year":"2018","unstructured":"Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A et al (2018) Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: clinical and laboratory correlates of remission duration. Arthritis Care Res (Hoboken) 70(7):1046\u20131051. https:\/\/doi.org\/10.1002\/acr.23435","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7792_CR64","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/acr.22477","volume":"67","author":"CY Chang","year":"2015","unstructured":"Chang CY, Meyer RM, Reiff AO (2015) Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy. Arthritis Care Res Hoboken 67:658\u2013666. https:\/\/doi.org\/10.1002\/acr.22477","journal-title":"Arthritis Care Res Hoboken"},{"issue":"8","key":"7792_CR65","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00296-013-2884-z","volume":"34","author":"E Iglesias","year":"2014","unstructured":"Iglesias E, Torrente-Segarra V, Bou R, Ricart S, Gonz\u00e1lez MI, S\u00e1nchez J et al (2014) Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-\u03b1 therapy: a clinical practice observational study of patients who discontinued treatment. Rheumatol Int 34(8):1053\u20131057. https:\/\/doi.org\/10.1007\/s00296-013-2884-z","journal-title":"Rheumatol Int"},{"issue":"10","key":"7792_CR66","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00296-012-2468-3","volume":"33","author":"J Post\u0119pski","year":"2013","unstructured":"Post\u0119pski J, Kobusi\u0144ska K, Olesi\u0144ska E, Osi\u0144ska V, Opoka-Winiarska V (2013) Clinical remission in juvenile idiopathic arthritis after termination of etanercept. Rheumatol Int 33(10):2657\u20132660. https:\/\/doi.org\/10.1007\/s00296-012-2468-3","journal-title":"Rheumatol Int"},{"issue":"3","key":"7792_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/14712598.2023.2185132","volume":"23","author":"A Tanatar","year":"2023","unstructured":"Tanatar A, Akg\u00fcn \u00d6, \u00c7a\u011flayan \u015e, Ba\u011flan E, Otar Yener G, \u00d6zt\u00fcrk K, Aktay Ayaz N (2023) Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes. Expert Opin Biol Ther 23(3):305\u2013313. https:\/\/doi.org\/10.1080\/14712598.2023.2185132","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"7792_CR68","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.apmr.2017.05.030","volume":"99","author":"G Kuntze","year":"2018","unstructured":"Kuntze G, Nesbitt C, Whittaker JL, Nettel-Aguirre A, Toomey C, Esau S et al (2018) Exercise therapy in juvenile idiopathic arthritis: a systematic review and meta-analysis. Arch Phys Med Rehabil 99(1):178-193.e1. https:\/\/doi.org\/10.1016\/j.apmr.2017.05.030","journal-title":"Arch Phys Med Rehabil"},{"issue":"13","key":"7792_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19137793","volume":"25","author":"AR Azab","year":"2022","unstructured":"Azab AR, Kamel FH, Basha MA, Alrawaili SM, Aloraini GS, Hassan SM et al (2022) Impact of clinical pilates exercise on pain, cardiorespiratory fitness, functional ability, and quality of life in children with polyarticular juvenile idiopathic arthritis. Int J Environ Res Public Health 25(13):7793. https:\/\/doi.org\/10.3390\/ijerph19137793","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"7792_CR70","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00296-023-05380-9","volume":"43","author":"A Di Ludovico","year":"2023","unstructured":"Di Ludovico A, La Bella S, Di Donato G, Felt J, Chiarelli F, Breda L (2023) The benefits of physical therapy in juvenile idiopathic arthritis. Rheumatol Int 43(9):1563\u20131572. https:\/\/doi.org\/10.1007\/s00296-023-05380-9","journal-title":"Rheumatol Int"},{"issue":"3","key":"7792_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.32641\/rchped.v90i3.886","volume":"90","author":"N P\u00e9rez Ram\u00edrez","year":"2019","unstructured":"P\u00e9rez Ram\u00edrez N, Nahuelhual Cares P, San Mart\u00edn Pe\u00f1ailillo P (2019) Efectividad de la terapia Watsu en pacientes con artritis idiop\u00e1tica juvenil. Un ensayo cl\u00ednico controlado paralelo, aleatorio y simple ciego [Effectiveness of Watsu therapy in patients with juvenile idiopathic arthritis. A parallel, randomized, controlled and single-blind clinical trial]. Rev Chil Pediatr 90(3):283\u2013292. https:\/\/doi.org\/10.32641\/rchped.v90i3.886","journal-title":"Rev Chil Pediatr"},{"issue":"3","key":"7792_CR72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3899\/jrheum.220261","volume":"50","author":"R Berard","year":"2023","unstructured":"Berard R, Ng HY, Human A, Piskin D, Dhalla M, Gottlieb C et al (2023) Canadian rheumatology association recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. J Rheumatol 50(3):390\u2013399. https:\/\/doi.org\/10.3899\/jrheum.220261","journal-title":"J Rheumatol"},{"issue":"4","key":"7792_CR73","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5195\/jmla.2018.345","volume":"106","author":"MB Eriksen","year":"2018","unstructured":"Eriksen MB, Frandsen TF (2018) The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc 106(4):420\u2013431. https:\/\/doi.org\/10.5195\/jmla.2018.345","journal-title":"J Med Libr Assoc"},{"key":"7792_CR74","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/acr.23922","volume":"72","author":"A Chhabra","year":"2020","unstructured":"Chhabra A, Oen K, Huber AM, Shift NJ, Boire G, Benseler SM et al (2020) Real-world effectiveness of common treatment strategies for juvenile idiopathic arthritis: results from a Canadian cohort. Arthritis Care Res (Hoboken). 72:897\u2013906. https:\/\/doi.org\/10.1002\/acr.23922","journal-title":"Arthritis Care Res (Hoboken)."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07792-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07792-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:02:17Z","timestamp":1769763737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07792-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7792"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07792-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}